IFNG and cancer: Regarding tumor antigen-targeting mAbs, it was demonstrated that Trastuzumab-coated cancer cells could induce IFN-γ production by human NK cells, especially in the presence of IL-12, and IFN-γ release was considered an important factor for Trastuzumab-antitumor activity (56).